{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T07:10:41Z","timestamp":1713942641979},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,8]]},"DOI":"10.7759\/cureus.30077","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T19:57:25Z","timestamp":1665259045000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case Report of Sitagliptin-Induced Angioedema"],"prefix":"10.7759","author":[{"given":"Nava R","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharosa","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saral","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalasa","family":"Pokhrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajwal","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1205","article-title":"Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes","volume":"97","author":"Muscelli E","year":"2012","unstructured":"Muscelli E, Casolaro A, Gastaldelli A, et al.. Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. J Clin Endocrinol Metab. 2012, 97:2818-26. 10.1210\/jc.2012-1205","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","unstructured":"Januvia (sitagliptin tablets) prescribing information. (2011). Accessed. 08\/15\/2022: https:\/\/www.merck.com\/product\/usa\/pi_circulars\/j\/januvia\/januvia_pi.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.12-RAI-0493","article-title":"Recent advances in drug-induced  angioedema","volume":"61","author":"Inomata N","year":"2012","unstructured":"Inomata N. Recent advances in drug-induced  angioedema. Allergol Int. 2012, 61:545-57. 10.2332\/allergolint.12-RAI-0493","journal-title":"Allergol Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","article-title":"Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema","volume":"54","author":"Brown NJ","year":"2009","unstructured":"Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension. 2009, 54:516-23. 10.1161\/HYPERTENSIONAHA.109.134197","journal-title":"Hypertension"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0574","article-title":"Sitagliptin-associated angioedema","volume":"35","author":"Gosmanov AR","year":"2012","unstructured":"Gosmanov AR, Fontenot EC. Sitagliptin-associated angioedema. Diabetes Care. 2012, 35:e60. 10.2337\/dc12-0574","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12948-021-00164-7","article-title":"Angioedema associated with dipeptidyl peptidase-IV inhibitors","volume":"19","author":"Cassano N","year":"2021","unstructured":"Cassano N, Nettis E, Di Leo E, Ambrogio F, Vena GA, Foti C. Angioedema associated with dipeptidyl peptidase-IV inhibitors. Clin Mol Allergy. 2021, 19:24. 10.1186\/s12948-021-00164-7","journal-title":"Clin Mol Allergy"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/L16-0649","article-title":"Sitagliptin and angioedema","volume":"167","author":"Arcani R","year":"2017","unstructured":"Arcani R, Martinez S, Gayet S. Sitagliptin and angioedema. Ann Intern Med. 2017, 167:142-3. 10.7326\/L16-0649","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-10-7","article-title":"Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes","volume":"10","author":"Williams-Herman D","year":"2010","unstructured":"Williams-Herman D, Engel SS, Round E, et al.. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord. 2010, 10:7. 10.1186\/1472-6823-10-7","journal-title":"BMC Endocr Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118353-a-rare-case-report-of-sitagliptin-induced-angioedema","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:13Z","timestamp":1707508213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118353-a-rare-case-report-of-sitagliptin-induced-angioedema"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.30077","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,8]]}}}